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SIGNIFIKAN PATOFISIOLOGI DAN PERANAN EKSOGENUS HIDROGEN 
SULFIDA DALAM KEADAAN HIPERTENSI BERSAMA DIABETIS DAN 
KESANNYA KE ATAS FUNGSI EKSKRETORI DAN HEMODINAMIK 
GINJAL 
 
ABSTRAK 
 
Hipertensi dan diabetes merupakan morbiditi yang sering wujud bersama. Kedua-
duanya saling mengaruh dan eksaserbat di antara satu sama lain. Pradispos hipertensi 
dan diabetes terhadap perkembangan penyakit kardiovaskular (cardiovascular 
disease, CVD) dan penyakit ginjal adalah komplikasi utama mereka. Kewujudan 
bersama hipertensi dan diabetes akan mengakibatkan perkembangan nefropati. 
Endogenus H2S dikenali sebagai pemindah gas baru. Tisu vaskular mampu menjana 
jumlah H2S yang boleh dikira dengan kepekatan ~46µM dalam serum tikus. H2S 
terlibat dalam mengawal atur tekanan darah dan juga mengawal fungsi glomerular 
(vaskular) dan tubular ginjal.  Kajian ini dijalankan untuk menguji hipotesis bahawa 
eksogenus H2S merendahkan tekanan darah serta mengurangkan perkembangan 
nefropati dalam tikus diabetes hipentensi. Model tikus hipertensi SHR dan DOCA-
salt digunakan. Hipertensi DOCA-salt dihasilkan daripada tikus WKY. Diabetes 
diaruh dengan satu injeksi tunggal streptozotocin (STZ) pada dos 40 mg/kg dalam 
suatu sediaan sejuk penampan natrium sitrat (0.1 mol/L, pH 4.5) secara 
intraperitoneum. Satu kumpulan diabetes diberikan NaHS, satu penderma H2S, pada 
dos 56µmol/kg secara intraperitoneum dalam salin pada masa yang sama setiap hari 
selama 5 minggu. Tekanan darah diukur pada tikus yang sedar dan pada akhir 
tempoh rawatan, ia diukur  pada tikus yang dibius Di samping itu, PWV (pulse wave 
xviii 
 
velocity) dan perfusi darah kortikal ginjal juga diperhatikan. Pengumpulan data 
metabolik bagi kajian fungsi renal dilakukan pada hari 0, 21 dan 33 daripada 35-hari 
kajian.  Tahap H2S, dalam plasma and urin, kepekatan kreatinin dan elektrolit diukur 
pada tiga keadaan yang berbeza sepanjang tempoh 35-hari.  Tahap H2S dalam plasma 
dan urin serta kepekatan kreatinin diukur secara spektrofotometri. Data, min±SEM 
dianalisis menggunakan ANOVA dan kesignifikanan secara statistik ditetapkan pada 
p< 0.05. Kumpulan tikus hipertensi diabetes mempunyai tekanan darah yang lebih 
tinggi, tahap H2S dalam plasma dan urin yang rendah serta ketidakfungsian ginjal 
sebagimana yang terbukti berdasarkan kreatinin plasma yang meningkat, klearans 
kreatinin dan pengurangan nisbah natrium, kalium dalam urin dan perfusi darah 
kortikal ginjal. Di samping itu kencing tikus hipertensi diabetes mempunyai lebih 
tinggi nadi gelombang halaju. Tambahan pula, tikus diabetes mempamerkan 
peningkatan klearans kreatinin, natrium plasma, kumuhan ekskresi natrium mutlak 
dan pecahan kumuhan natrium. NaHS, penderma eksogenus H2S mengurangkan 
tekanan darah, meningkatkan tahap H2S dalam tikus diabetes hipertensi serta 
memulihkan ketidakfungsian ginjal aruhan -STZ. Di samping itu, eksogenus H2S 
mengurangkan natrium plasma dan meningkatkan klearans kreatinin dan kumuhan 
natrium mutlak dalam tikus yang dirawat.  Dapatan kajian ini mencadangkan bahawa 
pengambilan atau pemberian eksogenus H2S  merendahkan tekanan darah dan secara 
signifikannya merendahkan aruhan – STZ dalam kreatinin plasma, mengurangkan 
nisbah natrium : kalium dalam urin dan mengurangkan perfusi darah kortikal ginjal, 
yang mampu memberi perlindungan terhadap perkembangan nefropati aruhan-STZ 
dalam tikus hipertensi. 
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PATHOPHYSIOLOGICAL SIGNIFICANCE AND THE ROLE OF 
EXOGENOUS HYDROGEN SULFIDE (H2S) IN A COMBINED STATE OF 
HYPERTENSION AND DIABETES AND ITS EFFECT ON RENAL 
EXCRETORY AND HAEMODYNAMIC FUNCTIONS 
 
 
ABSTRACT 
 
Hypertension and diabetes is a common co-morbidity that often coexists. Both 
diseases serve to induce and exacerbate each other. Hypertension and diabetes 
predispose the development of cardiovascular disease (CVD) and renal disease as 
their major complications. Coexistence of hypertension and diabetes results in rapid 
development of nephropathy. Endogenous H2S is recognized as a novel gaseous 
transmitter. Vascular tissues are capable of generating the measurable amounts of 
H2S with a concentration of ~46µM in the rat serum. H2S is involved in the 
regulation of blood pressure and also implicated in controlling the renal glomerular 
(vascular) and tubular functions. Present study was undertaken to test the hypothesis 
that exogenous H2S lowers the blood pressure and decreases the progression of 
nephropathy in hypertensive diabetic rats. SHR and DOCA-salt hypertension rat 
models were used in this study. DOCA-salt hypertension was produced from WKY 
rats. Diabetes was induced with a single injection of streptozotocin (STZ) at a dose of 
40 mg/kg in freshly prepared ice cold sodium citrate buffer (0.1 mol/L, pH 4.5), 
intraperitoneally. One set of diabetic groups received NaHS, a H2S donor, at a dose 
of 56µmol/kg intraperitoneally in saline at the same time daily for 5 weeks. Blood 
pressure was measured in conscious rats and at the end of the treatment period in 
surgically prepared anesthetized rats. In addition, pulse wave velocity (PWV) and 
renal cortical blood perfusion were also observed. Metabolic data collection for renal 
xx 
 
function study was performed on days 0, 21 and 33 of a 35-day study. Plasma and 
urinary H2S levels, creatinine concentrations and electrolytes were measured on three 
different occasions throughout the 35-day period. Plasma and urinary H2S and 
creatinine concentrations were measured spectrophotometrically. Data, mean±SEM 
were analyzed using ANOVA and statistical significance was set at p < 0.05. 
Diabetic hypertensive groups of rats had higher blood pressure, low plasma and 
urinary H2S levels and renal dysfunction as evidenced by increased plasma 
creatinine, creatinine clearance and decreased urinary sodium to potassium ratio and 
renal cortical blood perfusion. In addition diabetic hypertensive rats had higher pulse 
wave velocity. Moreover diabetic rats exhibited increased creatinine clearance, 
plasma sodium, absolute sodium excretion and fractional sodium excretion. NaHS, a 
donor of exogenous H2S reduced the blood pressure and pulse wave velocity, 
increased the H2S levels in hypertensive diabetic rats and reversed the STZ-induced 
renal dysfunction. In addition, exogenously administered H2S decreased the plasma 
sodium and increased the creatinine clearance and absolute sodium excretion in 
treated rats. The findings of the present study suggest that exogenously administered 
hydrogen sulfide lowers the blood pressure and significantly reverses the STZ-
induced increase in plasma creatinine, decrease in urinary sodium potassium ratio 
and reduced renal cortical blood perfusion, thereby conferring the protection against 
the progression of STZ-induced nephropathy in hypertensive rats. 
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CHAPTER 1 
INTRODUCTION 
                                    
1.1 Heart 
1.1.1 Basic anatomy 
The heart is a  muscular organ found in all animals with circulatory system 
(including all vertebrates), that is responsible for pumping blood throughout the 
blood vessels by repeated, rhythmic contractions. The term “cardiac‟‟ related to the 
heart comes from the Greek word kardia, for “heart” (Cohen, 2004). 
 
The human heart is composed of cardiac muscle, which is an involuntary 
striated muscle tissue found only in this organ, and connective tissue. On the average 
human heart, beats at 72 beats per minute, roughly beats 2.5 billion times during an 
average sixty five years  of lifespan, and weighs approximately 250 to 300 grams (9 
to 11 oz) in females and 300 to 350 grams (11 to 12 oz) in males (Kumar et al., 
2005).  
 
Heart is placed obliquely anterior to the vertebral column and behind the body 
of sternum so that 1/3 of it lies to the right and 2/3 lies to the left of median plane. It 
is enclosed in a double-walled sac called the pericardium. The superficial part of this 
sac is called the fibrous pericardium (Gavaghan, 1998). The outer wall of the human 
heart is composed of three layers. The outer layer is called the epicardium, or visceral 
pericardium since it is also the inner wall of the pericardium. The middle layer is 
called the myocardium and is composed of muscle which contracts. The inner layer 
is called the endocardium and is in contact with the blood that the heart pumps and  it 
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also merges with the inner lining (endothelium) of blood vessels and covers heart 
valves (MedicaLook, 2007).  
 
The human heart has four chambers, two superior atria and two inferior 
ventricles. The atria are the receiving chambers and the ventricles are the discharging 
chambers. The right ventricle discharges into the lungs to oxygenate the blood. The 
left ventricle discharges its blood towards the rest of the body via the aorta. The 
pathway of blood through the human heart consists of a pulmonary circuit and a 
systemic circuit. Blood flows through the heart in one direction, from the atria to the 
ventricles, and out of the great arteries. This is made possible by the presence of four 
valves  which are the tricuspid valve, the mitral valve, the aortic valve, and the 
pulmonary valve (Marieb & Nicpon, 1990).  
 
Figure 1.1 Chambers and four valves of the heart along with the main blood vessels 
entering and leaving the heart, adapted from (Chung, 1990). 
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1.1.2 Physiology of heart 
Heart acts as a functional syncytium and is divided into right side and left side 
heart. Function of the right side of heart is to collect de-oxygenated blood, in the 
right atrium, from the body via superior and inferior vena cavae and pump it, through 
the tricuspid valve into the lungs termed as pulmonary circulation. In the lungs there 
is oxygenation of blood through the passive process of diffusion. The left sided heart 
collects oxygenated blood from the lungs into the left atrium. From the left atrium the 
blood moves to the left ventricle, through the bicuspid valve, which pumps it out to 
the body via the aorta. On both sides, the lower ventricles are thicker and stronger 
than the upper atria. The muscle wall surrounding the left ventricle is thicker than the 
wall surrounding the right ventricle due to the higher force needed to pump the blood 
through the systemic circulation (Scott, 1986). 
 
The one complete beat of the heart, that is one systole followed by one diastole, 
is referred as one cardiac cycle. The duration of one cardiac cycle in human beings is 
0.8 seconds. Systole lasts for 0.3 seconds and diastole lasts for 0.5 seconds (Guyton, 
2006). 
 
 
1.2  Blood vessels 
Blood leaves the heart through the arteries, which conduct the oxygenated 
blood (except in the case of the pulmonary artery) to the various tissues and organs. 
Deoxygenated blood returns from the tissues and organs to the heart via a set of 
vessels, called veins (except the pulmonary vein) (Kahle et al., 1993).  
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The blood vessels are composed of arteries, arterioles, capillaries, venules, and 
veins. The actual exchange of oxygen, carbon dioxide, foodstuffs and waste matter 
between the blood and the tissue fluid occurs in microscopically small vessels, called 
capillaries (Ivy Rose Holistic, 2003). 
 
Structurally, vessel walls are composed of three "tunics" (layers). 
1. Tunica intima (innermost): Consists of endothelium (simple squamous epithelium) 
which forms a smooth, flat, low friction surface. All vessels have this layer, and all 
but the teeny-tiniest have a basement membrane associated with the endothelium. 
 
2. Tunica media (middle): Consists of smooth muscle cells and elastic connective 
tissue surrounding the interna. This layer is responsible for vasoconstriction and 
vasodilation. 
 
3. Tunica adventitia (outer): Consists of connective tissue, surrounds entire vessel 
loaded with lots of collagen, and some elastin (Derrickson & Tortora, 2006). 
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1.3  Kidney 
1.3.1 Basic anatomy 
In human beings, there are two kidneys one on each side of spine, located in 
the abdominal cavity called the retroperitoneal space. They are approximately at the 
vertebral level T12 to L3 (Walter F. & Boron, 2004). 
 
Each adult kidney weighs between 125 and 170 grams in males and between 
115 and 155 grams in females. The left kidney is typically slightly larger than the 
right (Glodny B et al., 2009). 
 
 
The kidney has a bean-shaped structure. On medial side of each kidney there is 
a depression called  hilum, at which the renal artery and nerve enters the organ, and 
the renal vein and ureter leaves the kidney (Marieb & Hoehn, 2007). 
 
Kidney is divided into two major structures, outer is the renal cortex and inner 
is called renal medulla. Nephrons, the urine-producing functional unit of the kidney, 
span the cortex and medulla (Shier, 2003). The initial filtering portion of a nephron is 
the renal corpuscle, located in the cortex, which is followed by a renal tubule that 
passes from the cortex deep into the medullary pyramids and ultimately drain into a 
single collecting duct. The tip, or papilla, of each pyramid empties urine into a minor 
calyx, minor calyces empty into major calyces, and major calyces empty into the 
renal pelvis, which becomes the ureter (Applegate, 2000). 
 
The kidneys receive blood from the renal arteries, left and right, which branch 
directly from the abdominal aorta. Despite their relatively small size, the kidneys 
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receive approximately 20% of the cardiac output. Each renal artery branches into 
segmental arteries, dividing further into interlobar arteries which penetrate the renal 
capsule and extend through the renal columns between the renal pyramids. The 
interlobar arteries then supply blood to the arcuate arteries that run through the 
boundary of the cortex and the medulla. Each arcuate artery supplies several 
interlobular arteries that feed into the afferent arterioles that supply the glomeruli 
(Walter F. & Boron, 2004). 
 
After filtration, the blood moves through a small network of venules that 
converge into interlobular veins. As with the arteriole distribution, the veins follow 
the same pattern, the interlobular veins provide blood to the arcuate veins then back 
to the interlobar veins which unite to form the renal vein exiting at the hilus of the 
kidney. The renal veins return the blood to inferior vena cava (Vander, 1995; 
Applegate, 2000). 
 
The kidney and nervous system communicate via the renal plexus, whose 
fibers course along the renal arteries to reach the kidney. Input from the sympathetic 
nervous system triggers vasoconstriction in the kidney, thereby reducing renal blood 
flow. The kidney is devoid of input from the parasympathetic nervous system (Bard, 
2003). 
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Fig 1.2 Anatomy of kidney 
1. Renal pyramid • 2. Interlobular artery • 3. Renal artery • 4. Renal vein 5. Renal 
hilum • 6. Renal pelvis • 7. Ureter • 8. Minor calyx • 9. Renal capsule • 10. Inferior 
renal capsule • 11. Superior renal capsule • 12. Interlobular vein • 13. Nephron • 
14. Minor calyx • 15. Major calyx • 16. Renal papilla • 17. Renal column. 
Adapted from (GNU Free Documentation License 3 November 2008 Version 1.3) 
 
 
1.3.2  Physiology of kidney  
The kidney participates in whole-body homeostasis, regulating acid-base 
balance, electrolyte concentrations, extracellular fluid volume, and regulation of 
blood pressure. The kidney accomplishes these homeostatic functions both 
independently and in combination with other organs, particularly those of the 
endocrine system (Edemir et al., 2011).  
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Most of the kidney's functions are completed by the simple mechanisms of 
filtration, reabsorption, and secretion that take place in the nephron. Filtration, which 
takes place at the renal corpuscle, is the process by which cells and large proteins are 
filtered from the blood to make the glomerular filtrate that will eventually become 
urine. Reabsorption is the transport of molecules from this ultrafiltrate and into the 
blood. Secretion is the reverse process, in which molecules are transported in the 
opposite direction, from the blood into the urine (Guyton, 1991b). 
 
 
1.4  Blood pressure 
Blood pressure is defined as the pressure exerted by the blood against any unit 
area of vessel wall (Guyton, 1991a). Blood pressure is the resultant of the activity of 
heart and blood vessels. Simply, blood pressure is equal to cardiac output multiplied 
by total peripheral resistance.  The normal blood pressure ranges are systolic blood 
pressure 90-119 mmHg and diastolic blood pressure 60-79 mmHg (Chobanian et al., 
2003). 
 
Many interrelated physiological mechanisms are involved in maintaining the 
blood pressure including sympathetic and parasympathetic nerves, baroreceptors, 
circulatory hormones and local autoregulatory mechanisms. Derangement in these 
factors contributes to the elevation of blood pressure (Beevers et al., 2001).  
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1.5  Hypertension 
Hypertension is a common worldwide health problem and about 972 million 
individuals are suffering from this chronic illness (Hajjar et al., 2006). It is an 
important health challenge in developed as well as in developing countries. The 
yearly estimated cost on hypertension treatment in USA exceeds USD 66 billion 
(Turek et al., 2010).  
 
Hypertension is a chronic medical illness, defined as a sustained elevation of 
blood pressure above normal. It is also referred to as high blood pressure and 
abbreviated as HT, HTN or HPN. The word "hypertension", generally refers to 
systemic, arterial hypertension (Maton, 1993). It is associated with increase in the 
peripheral vascular resistance and structural changes in the wall of blood vessels 
(Tanoue et al., 2003). Persistent hypertension is one of the risk factors for stroke, 
ischemic heart diseases such as myocardial infarction and angina pectoris, congestive 
heart failure, aneurysm and chronic renal failure (Pierdomenico et al., 2009). 
Hypertension is also linked with retinopathy and encephalopathy (Porta et al., 2005). 
A mean arterial pressure of 50% or more above average is linked with high mortality 
rate until and unless treated efficiently (Guyton & Hall, 2005). 
 
Hypertension is classified as essential (primary) hypertension and secondary 
hypertension. In essential or primary hypertension there is no detectable medical 
cause to explain the rise in blood pressure. It is common; about 90-95% of the 
patients have essential hypertension. Secondary hypertension indicates that the high 
blood pressure is a result of another condition (i.e., secondary to), such as kidney 
disease (Guyton, 2006). 
10 
 
1.6  Experimental models of hypertension 
A number of rat models of hypertension are available for research purpose, 
including inbred strains, congenic lines, transgenic animals and recombinant inbred 
strains. All these models have been extremely helpful in exploring the physiological 
mechanisms that underlie the hypertension (Yagil & Yagil, 2000). 
 
All these models are broadly divided into three classes based on etiology i.e. 
genetic, renal and pharmacologically induced. The most common genetic models of 
hypertensions are spontaneously hypertensive rats (SHR), severe hypertension stroke 
prone (SHR-SP) and Dahl salt sensitive rats (DSS). Depending on renal etiology 
unilateral nephrectomized DOCA-salt rat (UniNx DOCA salt) and renovascular 
hypertension (Goldblatt 2K1C rat) are commonly used. As far as the 
pharmacologically induced models are concerned L-NAME and angiotensin II 
treated rats are widely accepted. 
      
1.6.1  Essential hypertension/SHR 
Spontaneously hypertensive rats (SHR) are the model of essential 
hypertension. Since 1960s they are widely used to study the cardiovascular diseases 
(Pinto et al., 1998). The development of hypertension starts at the age of 5 to 6 weeks 
and typical vascular and cardiac structural changes are evident at approximately 40-
50 weeks of age (Conrad et al., 1995). The development of hypertension is linked to 
the altered structural and functional changes in kidney (Rettig, 1993). In addition the 
over activity of sympathetic nervous system and increase in the renal nerve activity 
contribute to the hypertension (Oparil, 1986). 
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1.6.2  Deoxycorticosterone acetate (DOCA)-salt hypertension 
DOCA-salt induced hypertension is a model of secondary hypertension, in 
which one kidney of the rat is removed and is administered with deoxycorticosterone 
acetate (DOCA) to produce the hypertension. It is a model of volume expansion. The 
pathophysiology is different as administered DOCA-salt leads to the salt and water 
retention resulting in hypertension. The increased level of sodium and water induced 
by DOCA is maintained, as there is only one kidney which is unable to handle this 
sodium and water overload. The level of renin remains low and hypertension is 
maintained by sodium and water retention, so extracellular volume expansion is the 
key pathophysiological mechanism in this model (Soszynski et al., 1997). The other 
possible mechanisms include the decrease in arterial baroreceptor‟s reflex activity in 
the development of salt sensitive hypertension (Grisk & Rettig, 2004). There is also 
the contribution of renal efferent nerve activity in the development of hypertension 
through increasing the renal sodium retention as in this model the renal denervation 
postpones and decreases the severity of hypertension (Oparil, 1986). So DOCA-salt 
induced model is sodium loaded, volume overloaded and low renin hypertension. 
 
 
1.7  Diabetes mellitus 
There has been an increase in the prevalence of diabetes mellitus over the past 
40 years, both in the US and worldwide. The worldwide prevalence of diabetes in 
year 2000 was approximately 2.8% and is estimated to grow to 4.4% by the year 
2030, that will lead to a rise in the number of diabetic patients from 171 million in 
2000 to  350 million in 2030 (Wild et al., 2004). 
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Diabetes is defined as a chronic metabolic disorder that affects the metabolism 
of carbohydrates and other nutrients as a result of impaired insulin release and/or 
insulin resistance resulting in hyperglycemia (Tierney, 2002). Diabetes mellitus is 
classified into Type I and Type II diabetes mellitus. Type 1 diabetes mellitusis 
characterized by loss of the insulin-producing beta cells of the islets of Langerhans in 
the pancreas leading to a deficiency of insulin. It is either immune-mediated or 
idiopathic (Boon & Davidson, 2006). The majority of Type 1 diabetes is of the 
immune-mediated in nature, where the loss of beta cells is due to autoimmune attack 
mediated by T-cell (Johns Hopkins Autoimmune Disease Research Center, 2007 ). 
On the other hand Type II diabetes mellitus is characterized by the presence of 
insulin resistance or reduced insulin sensitivity, and with relatively reduced insulin 
secretion. This defective response of body tissues to circulating insulin involves the 
insulin receptor in cell membranes (Rother, 2007). The exact cause and mechanism is 
not fully understood in type II diabetes mellitus. Certain risk factors are associated 
with increased incidence of diabetes such as obesity, as 55% of patient diagnosed 
with type 2 diabetes mellitus have central obesity (Eberhart et al., 2004). Other 
factors include ageing, increasing body mass and decreased demands of physical 
activity and family history (Kopelman, 2000). Environmental factors also have been 
implicated in type II diabetes mellitus (Lang et al., 2008). Genetics are strongly 
linked with both types of diabetes mellitus (Walley et al., 2006).  
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1.8  Hypertension and diabetes mellitus 
Hypertension and diabetes often coexist. The diabetic persons have increased 
prevalence of developing the hypertension, one prospective study (that included 
12,550 adults), indicates that the development of diabetes in hypertensive patients is 
2.5 times greater as compared to normotensive subjects (National High Blood 
Pressure Education Program Working Group, 1994). Similarly, previous data 
suggests that there is increased prevalence of diabetes in hypertension and 
approximately 20% of hypertensive individuals have coexisting diabetes (Contreras 
et al., 2000). Moreover, both diseases serve to induce, as well as exacerbate each 
other (Sowers & Epstein, 1995). Both hypertension and diabetes predispose to the 
development of cardiovascular disease (CVD) and renal disease as their major 
complications (Sowers, 2004b). The combined presence of hypertension and diabetes 
in patients increases the risks of cardiovascular diseases by 75% (Adler et al., 2000). 
Diabetes mellitus and systemic hypertension promote the process of atherosclerosis, 
and their combination further increases this risk (Fuller, 1985).  
 
1.8.1  Complications of diabetes and hypertension 
Hypertension and diabetes are associated with marked abnormalities of 
cardiovascular structure and functions. Hypertension and diabetes both can induce 
coronary heart disease, infraction, cerebrovascular accidents, nephropathy and 
retinopathy and peripheral vascular diseases (George et al., 2000). 
 
Complications are generally divided into microvascular and macrovascular 
diseases. Microangiopathy is associated with retinopathy, neuropathy and 
nephropathy. Whereas the macroangiopathy is mostly evident with accelerated 
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atherosclerosis affecting the vital organs i.e. heart and brain (Calles-Escandon & 
Cipolla, 2001).  
 
Endothelial dysfunction is considered as the first step in the pathogenesis of 
micro and macro vascular complications of both diseases (Wong et al., 2010). 
Endothelium, the inner lining of blood vessels, releases certain chemical substances 
in response to acetylcholine. These substances are divided into two types according 
to the functions they perform (Wong et al., 2010). 
 
Endothelium-derived relaxing factors (EDRFs) including nitric oxide (NO), 
prostacyclin (PGI2) and endothelium-derived hyperpolarizing factors (EDHFs). All 
of them reduce the vascular tone. Opposite to the beneficial EDRFs endothelium also 
produce vasoconstrictors substance called as endothelial-derived constrictors factors 
(EDCFs). Prostaglandin H2, thromboxane A2 (TXA2), leukotrienes, endothelin, and 
superoxide anions are included in this category (Vanhoutte, 2009).  
 
A critical balance is required between EDRFs and EDCFs in order to maintain 
the vascular health and function. Hypertension and diabetes tend to disturb this 
balance by either increasing or decreasing the production of one or both (Vanhoutte 
et al., 2009).  
 
Hyperglycemia associated with diabetes modifies the endothelial function 
through a number of complex mechanisms including oxidative stress (Laight et al., 
2000), glycation of protein and lipids (Vlassara et al., 1992) and activation of protein 
kinase C (Hink et al., 2001). Similarly the endothelial dependent vasodilatation is 
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impaired in different animal models of hypertension including spontaneous 
hypertensive rats (Lüscher et al., 1990), salt induced hypertension (Jiménez et al., 
2007) and renovascular hypertension (Rühlc et al., 2006).  
 
 
 
                                 HYPERGLYCAEMIA 
 
 
                                  Glucose                                  PKC 
                                autoxidation                         activation      
 
        Polyol pathway                                                                               AGEs 
              activity                                                                                  formation   
 
 
         
                   Antioxidant                          arachidonic acid 
                     defence                                    metabolism     
 
  
 
 
                                                    Oxidative stress 
 
 
 
                                ENDOTHELIAL DYSFUNCTION    
 
Fig 1.3  Outline and interactions of hyperglycaemia-induced metabolic pathways 
potentially involved in the pathophysiology of endothelial dysfunction (Adapted 
from (De Vriese et al., 2000). 
 
*
AGEs= advanced glycation products, PKC= protien kinase C 
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1.8.2  Diabetic nephropathy 
Nephropathy is the hallmark of microvascular complications of diabetes. 
Enough supporting evidences are present that the basic pathophysiological 
mechanisms eventually leading to nephropathy are similar in type 1 and 2 diabetes  
(Parving, 2001). Hypertension either related to the diabetes or not, additionally 
damages the kidney resulting in complex patterns of nephropathy. The risk for the 
development of nephropathy is strongly linked to genetic factors and only 
approximately 40–50% of patients with either type 1 or type 2 diabetes will 
ultimately develop nephropathy (Lindner, 2003). 
 
Haemodynamic and structural changes are important in the development of 
diabetic nephropathy. Glomerular haemodynamic changes including hyperfiltration 
and hyperperfusion have been sighted as a key factor in the development of diabetic 
nephropathy and are found very early in the disease process (Ruggenenti et al., 
2001). Elevated intraglomerular pressure has been linked to an increase in mesangial 
cell matrix production and thickening of the glomerular basement membrane, 
eventually leading to glomerulosclerosis (Wolf et al., 2000).  Local haemodynamic 
stress also contributes to the structural changes of diabetic nephropathy by the local 
activation of cytokines and growth factors (Wolf, 2004). 
 
Abnormalities  in sodium reabsorption have been linked to glomerular 
hyperfiltration in diabetic nephropathy (Thomson et al., 2004), as the diabetes 
induced hypertrophy of tubules causes the increased reabsorption of sodium chloride 
(Chen et al., 2001). 
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As far as the structural abnormalities are concerned diabetes can affect all the 
compartments of the kidney. The structural changes range from the thickening of 
basement membrane to mesangial expansion, glomerulosclerosis (diffuse, nodular) 
fibrin cap lesion, capsular drop lesion,  endothelial foam, podocyte abnormalities, 
tubular atrophy, interstitial inflammation and interstitial fibrosis (Wolf, 2004). 
 
On the molecular level, five major pathways have been implicated in glucose-
mediated vascular and renal damage including increased polyol pathway flux, 
increased hexosamine pathway flux, activation of nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB), increased advanced glycation end-product 
(AGE) formation, stimulation of angiotensin II (ANG II) synthesis and activation of 
the protein kinase C (PKC) pathway. All of these pathways reflect a single 
hyperglycaemia-induced process of overproduction of reactive oxygen species (ROS) 
and oxidative stress (Wolf, 2004). 
 
Another factor which is linked to nephropathy is the activation of renin 
angiotensin aldosterone system (RAAS) found in tubular cells (Wolf & Ziyadeh, 
1997). Hyperglycemia stimulates expression of renin and angiotensinogen in 
mesangial and tubular cells (Vidotti et al., 2004). This stimulation results in an 
increase in local ANG II concentrations which in turn through autocrine and 
paracrine pathways induce the production of different cytokines and growth factors 
(Wolf & Ziyadeh, 1997). Previous experimental studies indicate that a high glucose-
mediated generation of ROS is responsible for the upregulation of angiotensinogen in 
proximal tubular cells (Hsieh et al., 2002). In fact, it has been shown that angiotensin 
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II is involved in almost every pathophysiological process implicated in the 
development of diabetic nephropathy (Wolf, 2004).  
 
Generally, as far as complications of both diseases are concerned hypertension 
and diabetes attack the common organs for end stage damage and potentiate the 
adverse prognostic effects of each other.  
 
 
1.9  Animal models of diabetic nephropathy 
Several rodent models with spontaneous diabetes such as fatty Zucker rat, Kuo 
kondo mouse, New Zeland obese mouse and Cohen diabetic rat (Janssen et al., 1999) 
are known but not completely assisting us to reveal the multifaceted pathophysiology 
of diabetes and its complications. Apart from these models, diabetes can be induced 
with streptozotocin (STZ) and other chemical agents and thus providing another set 
of animal model of diabetes. STZ induced diabetic rats develop typical diabetic 
haemodynamic and structural abnormities that correspond to the early stage of 
diabetes. These lesions include hyperfiltration, progressive thickening of basement 
membrane, albuminurea and renal hypertrophy (O'Donnell, 1993; Nobrega et al., 
2004). 
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1.9.1  SHR diabetic and DOCA (Deoxycorticosterone acetate)-salt HTN diabetic 
A large number of studies used STZ induced diabetes either with salt loaded 
hypertension (Korner et al., 1993) or with genetic hypertension (use of SHR) 
(Cojocel et al., 2005) in order to get the severe and rapid renal injury. It was reported 
earlier that the rise in creatinine clearance after the induction of diabetes was greater 
in the SHR-STZ animals suggesting that this may be a better model for studying 
„hyperfiltration‟ in diabetes. Similarly, SHR-STZ developed albuminuria more 
rapidly than WKY-STZ despite similar GFR in the two strains (Cooper et al., 1986). 
This proposes that hypertension may have a specific action in the acceleration of 
diabetic renal disease, independent of GFR.  
. 
The severity of diabetic lesions in these animals ranges from early diabetic 
nephropathy to full blown diabetic renal disease depending upon the duration of 
diabetic stage. SHR diabetic and DOCA-salt hypertension diabetic have 
demonstrated accelerated tubulointerstitial injury in form of vacuolization of tubular 
cells, tubular atrophy, infiltration of inflammatory cells and subsequent fibrosis of 
renal tissue (Cooper et al., 1986; Usui et al., 2003; Cojocel et al., 2005). 
 
 
1.10   Pathophysiology of hypertension with diabetes 
Several epidemiologic studies provide evidence for co-existence of 
hypertension and diabetes and indicate towards a common genetic and environmental 
factor promoting both diabetes and hypertension. Similarly, a combined state of 
hypertension, insulin resistance, hyperlipidaemia and central obesity have been 
documented (Reaven, 1988). It is documented that about 25–47% of persons with 
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hypertension have insulin resistance or impaired glucose tolerance (Lind et al., 
1995). The relationship of insulin resistance, diabetes and hypertension is very 
complex but interrelated. Increased activity of renin angiotensin aldosterone system 
(RAAS) in hypertension and diabetes has been proposed (Ogihara et al., 2002). This 
up regulation of RAAS results in the formation of reactive oxygen species (ROS) 
which in turn affects glucose utilization and blood pressure in a setting of diabetes 
and hypertension (Sowers, 2004a). At the same time RAAS mediates the increase in 
oxidative stress which further contributes to insulin resistance (Blendea et al., 2005). 
Furthermore the increased formation of angiotensin II results in increased 
aldosterone secretion from the adrenal gland leading to increased water and sodium 
absorption and hence aggravation of hypertension.  
 
Moreover increased secretion of aldosterone increases sympathetic nervous 
system activity and reduces baroreceptor‟s activity (McFarlane & Sowers, 2003). As 
such, renin angiotesin aldosterone system (RAAS) is mainly linked with 
hypertension combined with diabetes. In addition, quite a few other 
pathophysiological events are also suggested such the elevation of intracellular 
calcium concentration, vascular smooth muscle cell proliferation and atherosclerosis, 
and reduction in nitric oxide concentration or its bioavailability (Modan & Halkin, 
1991). It has also been shown that increased level of insulin also affects the reactivity 
of large vessels to vasodilator agents (Johnstone et al., 1993; Westerbacka et al., 
1999). 
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1.11   Hydrogen sulfide (H2S) 
Hydrogen sulphide (H2S), along with nitric oxide (NO) and carbon monoxide 
(CO), forms a group of biologically active gases that are termed as gasotransmitters 
or gasomediators. H2S, NO and CO once solely considered as metabolic poisons. 
Many other gases, including O2 and CO2, play equally, if not more, important and 
fundamental roles in human biology, yet H2S, NO, and CO have attracted attention 
because they exert fine, modulator control over cellular functions by influencing a 
range of intracellular signaling processes (Li et al., 2011). 
 
  H2S has the bad public image of a deadly “gas of rotten eggs”, recognized 
having a toxic potential equal to cyanide for last 300 years. As a toxicant, it mainly 
affects the brain, kidney and lungs (Beauchamp et al., 1984). H2S is the most 
recently discovered member in the family of gasotransmitter and, perhaps not 
surprisingly, has attracted a great deal of interest among the researchers over the past 
few years. H2S can be generated endogenously in many types of mammalian cells 
(Stipanuk & Beck, 1982). Endogenous H2S is recognized as a novel gaseous 
transmitter (Wang, 2002). The H2S concentration of rat serum is ~46µM (Zhao et al., 
2001). Besides the circulating H2S, a significant amount of H2S is produced in 
various tissues such as liver, kidney, pancreas, brain and blood vessels. For instance, 
the physiological concentration of H2S in brain tissue has been reported to be 50–160 
µM (Hosoki et al., 1997). Recent studies have shown that vascular tissues are 
capable of generating the measurable amounts of H2S (Zhao et al., 2001).  
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1.11.1   Production of H2S 
To date, quite a few scientists have comprehended the formation of H2S 
molecule naturally, at levels enough to modify cell function without causing cell 
death. H2S is synthesized in mammalian tissues via endogenous enzymes and by 
nonenzymatic pathways. As far as the enzymatic formation of H2S is concerned, two 
pyridoxal phosphate-dependent enzymes, cystathionine beta synthase (CBS) and 
cystathionine gama lyase (CSE) are responsible for the majority of the endogenous 
production of H2S in mammalian tissues that use l-cysteine as the main substrate 
(Stipanuk & Beck, 1982). The expression of CBS and CSE has been identified in 
many human and other mammalian cells, including those from the liver, heart, blood 
vessels, kidney, brain, skin fibroblasts and blood lymphocytes (Levonen et al., 2000). 
 
The expression of CBS and/or CSE is tissue specific. CBS is considered as a 
major endogenous enzyme for H2S production in the brain (Abe & Kimura, 1996). 
On the other hand CSE enzyme is concerned with the endogenous production in 
cardiovascular system. As in rat mesenteric artery and other vascular tissues CSE is 
the only H2S-generating enzyme that has been identified, cloned, and sequenced. The 
mRNA of this enzyme was expressed solely in vascular SMCs as detected by reverse 
transcriptase-polymerase chain reaction (RT-PCR) and in situ hybridization. No 
transcript of CSE was found in the endothelial layers of intact vascular tissues or 
cultured endothelial cells. Expression levels of CSE mRNA varied in different types 
of vascular tissues (Zhao et al., 2001). 
 
Previously it was considered that the vascular smooth muscle which expresses 
the CSE enzyme is the major source of H2S production. Recently it was reported that 
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the CSE enzyme is also expressed in the endothelium of mice aorta (Yang et al., 
2008a). 
 
Similarly it was reported that endothelium is another source of H2S but the 
enzymes responsible for the production of H2S are different as compared to smooth 
muscle H2S production. It has been demonstrated that 3-mercaptopyruvate 
sulfurtransferase (3MST) and cysteine aminotransferase (CAT) are localized to 
vascular endothelium in the thoracic aorta and produce H2S in rats. Both 3MST and 
CAT were expressed in the endothelium. Lysates of vascular endothelial cells 
produced H2S from cysteine and α-ketoglutarate (Shibuya et al., 2009). 
 
Whereas most emphasis has been placed on the enzymatic formation of H2S, 
the generation of this gas from bound sulfur (intracellular sulfur stores) may be 
important in certain cells and under certain conditions. Bound sulfide most likely 
occurs when H2S interacts with cysteine thiols to form stable persulfides, which, 
under reducing conditions, can release stored H2S confirming a nonenzymatic source 
of H2S (Searcy & Lee, 1998). H2S in vivo is metabolized by oxidation in 
mitochondria or by methylation in cytosol or scavenged by methemoglobin and is 
excreted mainly by the kidney as free or conjugated sulfate (Beauchamp et al., 1984). 
Notwithstanding these biochemical means for H2S catabolism, H2S is a powerful 
reducing agent and is likely to be consumed by endogenous oxidant species in the 
vasculature, such as peroxynitrite, superoxide, and hydrogen peroxide (Li et al., 
2011)  
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Fig.1.4 Endogenous enzymatic production and metabolism of H2S, Adapted from 
(Wang, 2002) 
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1.11.2  Physiological actions of H2S 
To date, much research into H2S has been centered upon its effects on 
individual body systems. Even though many systems have come under the spotlight, 
the effect of this gas on the cardiovascular system and in inflammation has attracted 
the most attention. Many other possible roles for endogenous H2S have been 
hypothesized in, for example, the peripheral and central nervous systems, pain 
appreciation and neurodegeneration, control of gastrointestinal and urogenital 
function, and endocrinology. 
 
  Some of the physiological actions of H2S which have been characterized since 
its discovery in relation to cardiovascular system are as follows:- it  has been shown 
to relax vascular smooth muscle cells, induce vasodilatation of isolated blood vessels, 
reduce blood pressure (Elrod et al., 2007), inhibit leukocyte–endothelial cell 
interactions in vivo (Zanardo et al., 2006), is a potent anti-inflammatory molecule, a 
potent antioxidant (under chronic conditions such as diabetes and hypertension), 
effectively inhibit apoptosis of a number of cell types (Kimura & Kimura, 2004), 
exert potent effects on mitochondrial function and respiration like NO (Nicholls, 
1975), protect the myocardium in ischemia reperfusion (I/R) injury (Bian et al., 
2006) and has profound effects on vascular growth formation and neointimal 
hyperplasia (Meng et al., 2007). Moreover H2S known to be cardioprotective in 
isolated rat hearts following coronary artery ligation, ischemia, or lipopolysaccharide 
(LPS) injection (Li et al., 2011). 
 
 
 
